ANP32B and hepatocellular carcinoma: Based on the median value of the expression of ANP32B and ANP32E, we divided the HCC patients into an HH subgroup (high expression levels of both ANP32B and ANP32E), an HL subgroup (high expression of ANP32B but low expression of ANP32E), an LH subgroup (low expression of ANP32B but high expression of ANP32E), and an LL subgroup (low expression levels of both ANP32B and ANP32E).